- Published at
- by zacks.com
mixed
mixed
VBI Vaccines, Inc. (VBIV) Reports Q4 Loss, Lags Revenue Estimates
VBI Vaccines, Inc. (VBIV) delivered earnings and revenue surprises of 0.00% and -62.73%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?